OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. Co. focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. We show 64 historical shares outstanding datapoints in our OPK shares outstanding history coverage, used to compute OPK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OPK market cap history over the course of time is important for investors
interested in comparing OPK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OPK versus a peer is one thing; comparing
OPK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OPK can fluctuate over the course of history.
With this page we aim to empower investors researching OPK by allowing them to research the OPK market cap history. |
Free OPK Email Alerts:
Video: The Importance of Market Cap
